Intracerebral hemorrhage

J M Gebel1, J P Broderick

  • 1Assistant Professor of Neurology, Stroke Institute, University of Pittsburgh Medical Center, PA 15213, USA.

Neurologic Clinics
|April 11, 2000
PubMed

Insights

Intracerebral hemorrhage (ICH) remains a leading cause of stroke-related death and disability, particularly in young Black individuals. Despite diagnostic advances, effective treatments are lacking, necessitating urgent clinical trials for new therapeutic strategies.

Area of Science:

  • Neurology
  • Neurosurgery
  • Public Health

Background:

  • Intracerebral hemorrhage (ICH) accounts for a significant proportion of strokes, leading to high rates of morbidity and mortality.
  • This is particularly pronounced in young Black populations.
  • Despite advances in diagnostic imaging like CT scans, patient outcomes have not significantly improved.

Purpose of the Study:

  • To highlight the urgent need for effective therapeutic interventions for ICH.
  • To emphasize the lack of proven treatments despite aggressive medical and surgical interventions.
  • To underscore the importance of timely treatment and the necessity for large-scale clinical trials.

Main Methods:

  • Review of current diagnostic and therapeutic approaches for ICH.
  • Analysis of existing clinical trial data regarding treatment efficacy.
  • Identification of emerging therapeutic strategies from experimental and clinical research.

Main Results:

  • No current therapeutic modality has demonstrated a clear benefit on long-term outcomes in randomized trials.
  • Aggressive interventions are often employed due to the critical nature of ICH presentations.
  • Emerging research suggests potential new therapeutic strategies, with time to treatment being a critical factor.

Conclusions:

  • Large, prospective, randomized, placebo-controlled trials are essential.
  • These trials should evaluate current treatment options and investigate novel therapeutic modalities.
  • Addressing the high burden of ICH requires robust scientific investigation and evidence-based treatment strategies.

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...